Abstract

Objectives. Postmenopausal osteoporosis, a major public health problem worldwide, is associated with low quality of life, morbidity, significant mortality and huge socio-economic burden. Therefore, this study aimed to investigate the effect of bioptron light therapy on postmenopausal osteoporosis.
Methods. Thirty postmenopausal women with hip osteoporosis, aged 50-60 years, were randomized into 2 equal groups. Group (A) received medical treatment in the form of calcium, vitamin D3 and sodium fluoride supplementation for 4 weeks (n = 15), while group (B) received the same medical treatment in addition to bioptron light therapy for 4 weeks (n = 15). The primary outcome was total hip T–score, while the secondary outcome was total score of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41). The outcome measures were evaluated pre- and post-treatment.
Results. Comparing both groups pre- and post-treatment revealed that there was a statistically non-significant difference in total hip T–score (P > 0.05). Also, total score of QUALEFFO-41 revealed a statistically non-significant difference pre-treatment (P > 0.05), while post-treatment, it revealed a statistically significant reduction (P < 0.05) in favour of group (B). The percentages of improvement post-treatment in total hip T–score and total score of QUALEFFO-41 were 2.4% and 15.65% in group (A), while they were 11.29% and 31.63% in group (B).
Conclusions. Bioptron light therapy is effective in treating postmenopausal women with hip osteoporosis through producing a greater improvement percentage in total hip T–score and improving their quality of life.

Key words:

Postmenopausal osteoporosis, Bioptron Light Therapy, Quality of Life Questionnaire